Syngenta and Novozymes launch unique biofungicide in Europe and Latin America

• Approvals enable partners to commercialize TAEGRO®, addressing critical grower needs in specialty and vegetable crops.

Basel / Switzerland, April 24, 2020 – Syngenta, a leading agricultural company, and Novozymes, the world leader in biological solutions, today announced that they are entering the commercialization phase of TAEGRO®. The two companies originally joined forces in 2012 to develop and market the product, and have now received the first wave of product approvals in Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Honduras, Italy, Netherlands, Romania, Slovenia, Spain, and United Kingdom. Several other approvals are expected across the EU and Latin America during the next 12 months, which will enable multiple product launches in 2020.

“We're delighted to see our collaboration with Novozymes entering the commercialization phase and excited about our launch plans. Over the last seven years, our journey together deepened our understanding of biologicals, and we are pleased to place a new tool in the hands of farmers” comments Jean-Philippe Albert, Global Head of Disease Control at Syngenta.

“This collaboration matches Syngenta’s global market strength in biocontrol and dedication to bring novel technologies to market with Novozymes’ deep knowledge of sustainable, biological solutions,” says Thomas Batchelor, Novozymes’ Vice President of BioAg Commercial. “As the developer and producer of TAEGRO®, we are really excited to see another microbial technology become available to farmers to help them sustainably combat crop diseases and avoid significant yield losses”.

Alleviating critical grower pain points and addressing the sustainability challenge

TAEGRO® is a microbial foliar fungicide with broad spectrum potential. When fruit and vegetable growers use TAEGRO® in the recommended crop management programs it protects against diseases such as powdery mildew and botrytis. Due to its microbial origin, low application rates, and short re-entry and pre-harvest intervals, TAEGRO® is a powerful tool that helps ensure compliance with food chain requirements and maximize marketable yields. The efforts behind the development and commercialization of TAEGRO® demonstrate both companies’ commitment to sustainability.

TAEGRO® is a registered trademark of Novozymes A/S.

About Syngenta
Syngenta is one of the world’s leading agriculture companies. Our ambition is to help safely feed the world while taking care of the planet. We aim to improve the sustainability, quality and safety of agriculture with world class science and innovative crop solutions. Our technologies enable millions of farmers around the world to make better use of limited agricultural resources. With 28,000 people in more than 90 countries we are working to transform how crops are grown. Through partnerships, collaboration and The Good Growth Plan we are committed to improving farm productivity, rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter at www.twitter.com/Syngenta and www.twitter.com/SyngentaUS.

About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners, and the global community, we improve agricultural and industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com.

NASDAQ OMX: NZYM-B • 6,500 employees • DKK 14,5 billion turnover • 30+ industries • 700+ products

Cautionary Statement Regarding Forward-Looking Statements

This document may contain forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.